Odunsi K - Search Results

1

Regulatory T cells, inherited variation, and clinical outcome in epithelial ovarian cancer.

Knutson KL, Maurer MJ, Preston CC, Moysich KB, Goergen K, Hawthorne KM, Cunningham JM, Odunsi K, Hartmann LC, Kalli KR, Oberg AL, Goode EL. Knutson KL, et al. Among authors: odunsi k. Cancer Immunol Immunother. 2015 Dec;64(12):1495-504. doi: 10.1007/s00262-015-1753-x. Epub 2015 Aug 23. Cancer Immunol Immunother. 2015. PMID: 26298430 Free PMC article.

2

Evaluation of beta1,4-galactosyltransferase as a potential biomarker for the detection of subclinical disease after the completion of primary therapy for ovarian cancer.

Odunsi K, Ghamande S, Chandrasekaran EV, Ta A, Moysich KB, Driscoll D, Matta K, Lele S. Odunsi K, et al. Am J Obstet Gynecol. 2002 Sep;187(3):575-80. doi: 10.1067/mob.2002.125888. Am J Obstet Gynecol. 2002. PMID: 12237630

3

NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.

Odunsi K, Jungbluth AA, Stockert E, Qian F, Gnjatic S, Tammela J, Intengan M, Beck A, Keitz B, Santiago D, Williamson B, Scanlan MJ, Ritter G, Chen YT, Driscoll D, Sood A, Lele S, Old LJ. Odunsi K, et al. Cancer Res. 2003 Sep 15;63(18):6076-83. Cancer Res. 2003. PMID: 14522938

4

SCP-1 cancer/testis antigen is a prognostic indicator and a candidate target for immunotherapy in epithelial ovarian cancer.

Tammela J, Jungbluth AA, Qian F, Santiago D, Scanlan MJ, Keitz B, Driscoll D, Rodabaugh K, Lele S, Old LJ, Odunsi K. Tammela J, et al. Among authors: odunsi k. Cancer Immun. 2004 Oct 18;4:10. Cancer Immun. 2004. PMID: 15487888

5

Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics.

Odunsi K, Wollman RM, Ambrosone CB, Hutson A, McCann SE, Tammela J, Geisler JP, Miller G, Sellers T, Cliby W, Qian F, Keitz B, Intengan M, Lele S, Alderfer JL. Odunsi K, et al. Int J Cancer. 2005 Feb 20;113(5):782-8. doi: 10.1002/ijc.20651. Int J Cancer. 2005. PMID: 15499633

6

Th1/Th2 CD4+ T cell responses against NY-ESO-1 in HLA-DPB1*0401/0402 patients with epithelial ovarian cancer.

Qian F, Gnjatic S, Jäger E, Santiago D, Jungbluth A, Grande C, Schneider S, Keitz B, Driscoll D, Ritter G, Lele S, Sood A, Old LJ, Odunsi K. Qian F, et al. Among authors: odunsi k. Cancer Immun. 2004 Nov 3;4:12. Cancer Immun. 2004. PMID: 15521719

7

Gene expression and prognostic significance in ovarian cancer.

Tammela J, Odunsi K. Tammela J, et al. Among authors: odunsi k. Minerva Ginecol. 2004 Dec;56(6):495-502. Minerva Ginecol. 2004. PMID: 15729202 Review.

8

Targeted therapy for epithelial ovarian cancer.

Sharma S, Odunsi K. Sharma S, et al. Among authors: odunsi k. Expert Opin Ther Targets. 2005 Jun;9(3):501-13. doi: 10.1517/14728222.9.3.501. Expert Opin Ther Targets. 2005. PMID: 15948670 Review.

9

OY-TES-1 expression and serum immunoreactivity in epithelial ovarian cancer.

Tammela J, Uenaka A, Ono T, Noguchi Y, Jungbluth AA, Mhawech-Fauceglia P, Qian F, Schneider S, Sharma S, Driscoll D, Lele S, Old LJ, Nakayama E, Odunsi K. Tammela J, et al. Among authors: odunsi k. Int J Oncol. 2006 Oct;29(4):903-10. Int J Oncol. 2006. PMID: 16964386

10

Usual adult body mass index is not predictive of ovarian cancer survival.

Moysich KB, Baker JA, Menezes RJ, Jayaprakash V, Rodabaugh KJ, Odunsi K, Beehler GP, McCann SE, Villella JA. Moysich KB, et al. Among authors: odunsi k. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):626-8. doi: 10.1158/1055-9965.EPI-06-1052. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17372264 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters